by Urokinase, also known as urokinase-type plasminogen activator uPA , is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form zymogen of the serine protease plasmin.
The global Urokinase market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Urokinase by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/global-urokinase-market-7112
Product Type Coverage Market Size and Forecast, Major Company of Product Type etc. :
Urokinase Powder
Urokinase Solution
Company Coverage Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc. :
Wanhua Biochem
NDPharm
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Application Coverage Market Size and Forecast, Different Demand Market by Region, Main Consumer Profile etc. :
Hospital
Clinic
Others
Region Coverage Regional Production, Demand and Forecast by Countries etc. :
North America U.S., Canada, Mexico
Europe Germany, U.K., France, Italy, Russia, Spain etc.
Asia-Pacific China, India, Japan, Southeast Asia etc.
South America Brazil, Argentina etc.
Middle East and Africa Saudi Arabia, South Africa etc.
